PIN29 COST-EFFECTIVENESS OF THE SEQUENTIAL USE OF ANIDULAFUNGIN AND ORAL VORICONAZOLE IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NON-NEUTROPHENIC PATIENTS IN MEXICO
May 1, 2010, 00:00
10.1016/S1098-3015(10)72936-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)72936-3/fulltext
Title :
PIN29 COST-EFFECTIVENESS OF THE SEQUENTIAL USE OF ANIDULAFUNGIN AND ORAL VORICONAZOLE IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NON-NEUTROPHENIC PATIENTS IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72936-3&doi=10.1016/S1098-3015(10)72936-3
First page :
Section Title :
Open access? :
No
Section Order :
511